NCT02332473 - A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2016

Conditions

Chronic Hepatitis B

Interventions

DRUG

Ypeginterferon alfa-2b

DRUG

Granulocyte-macrophage colony stimulating factor

Trial Locations (12)

Peking University First Hospital, Beijing

Peking University People's Hosopital, Beijing

Fuzhou Infectious Disease Hospital, Fuzhou

Xiamen Hospital of T.C.M, Xiamen

Nanfang Hospital, Guangzhou

Henan Provincial People's Hospital, Zhengzhou

Tongji Hospital, Huazhong University of Science & Technology, Wuhan

Xiangya Second Hospital, Central-south University, Changsha

Shenyang Sixed People's Hospital, Shenyang

Ruijing Hospital, Shanghai

Xijing Hospital, Xi’an

First Affiliated Hospital of Wenzhou Medical College, Wenzhou

All Listed Sponsors

collaborator

Peking University First Hospital

OTHER

lead

Xiamen Amoytop Biotech Co., Ltd.

INDUSTRY